Mike Blankenship, managing partner of Winston & Strawn’s Houston office, returns to Vcheck Global’s podcast RiskWatch to discuss de-SPAC due diligence priorities, M&A sectors and regions to watch, and risks facing biotech and digital health investors. You can listen to our first conversation with Mike Blankenship on the RiskWatch podcast.
This conversation covers:
- 00:42 – 01:45 Approaching De-SPAC deadlines
- 01:46 – 03:32 Reputational risk concerns when De-SPACing
- 03:33 – 04:41 Tips for target company due diligence
- 04:42 – 05:28 SPAC litigation patterns
- 05:29 -06:23 Inflation’s impact on tech investment
- 06:24 – 07:01 Sectors drawing SPAC attention
- 07:02 – 08:06 Conflict of interest concerns
- 08:07 – 11:15 ESG due diligence
- 11:16 – 12:04 M&A sectors and regions to watch
- 12:05 – 14:39 Theranos fraud due diligence failures
- 14:40 – 15:29 Interest in remote healthcare and telehealth solutions
Previous
